BTSG Raises 2026 Guidance as Specialty and Home Health Drive Growth
BrightSpring beat second-quarter estimates and raised its 2026 outlook as specialty, infusion and home health growth lifted margins and EBITDA.
Why it matters
Attributed market update with source link for portfolio context.